menu search

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report first quarter 2023 financial results after the U.S. financial markets close on Thursday, May 4, 2023. Oncternal’s management will host a webcast at 2:00 p.m. […] The post Oncternal Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results appear... Read More
Posted: Apr 27 2023, 21:00
Author Name: forextv
Views: 110732

Search within

Pages Search Results: